The Russian president, Vladimir Putin, announced today (August 11) that his country had won the world career to approve a COVVI-19 vaccine, several media reported. Despite clinical trials that for less than two months, the vaccine evolved through the Gamaleya Institute in Moscow has been safe, Putin said at a closet TV meeting, noting that one of his girls had already occurred , according to Reuters and Washington Correo. The Government first plans to vaccinate high -level equipment, such as fitness staff and teachers, with mass vaccination in October after starting the production of giant scale, according to Associated Press.
“It works effectively, it constitutes a solid immunity and, I repeat, all the mandatory evidence has passed,” Putin said at the meeting, according to the New York Times.
Researchers around the world, including in Russia, …
Develop knowledge integrity for clinic and manufacturing
A problem solution to optimize laboratory water use
The role of cytometry in healing research
Accelerate mycoplasma tests for the progression of therapy
A redesigned lipid vehicle for nucleic acids can succeed over the limits of existing vectors.
In this web seminar, Ethan Shelkey and Aurita Menezes will highlight the key facet of cell design in the cells.
Discover how animal models of choice provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists design the next revolutionary vaccines infectious diseases.
The multi -rational platform rationalizes workflows and provides real -time information, optimization of resources and ensures elegant and data -based operations
Learn to succeed over the demanding situations of viral transduction workflows.
Inventia Life Science, avant-garde of cell culture 3-D technologies, announces the launch of rastrum ™ allegro, a revolutionary progression in the generation of mobile culture 3-D designed to increase the discovery of drugs and studies on diseases with scalability, reproducibility and unprecedented. efficiency.
Learn how objective enrichment improves the discovery and characterization of viral pathogens.
© 1986-2025 The scientist. All rights reserved.